BioCentury
ARTICLE | Financial News

Critical Outcome Technologies financial update

September 16, 2013 7:00 AM UTC

Critical Outcome received conditional consent from the Toronto Stock Exchange-Venture to amend the expiry date of 11.3 million 18-month warrants to purchase a share at C$0.30. The warrants issued on M...